128 related articles for article (PubMed ID: 56980)
1. BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients.
Livingston RB; Fee WH; Einhorn LH; Burgess MA; Freireich EJ; Gottlieb JA; Farber MO
Cancer; 1976 Mar; 37(3):1237-42. PubMed ID: 56980
[TBL] [Abstract][Full Text] [Related]
2. Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study.
Livingston RB; Helibrun L; Lehane D; Costanzi JJ; Bottomley R; Palmer RL; Stuckey WJ; Hoogstraten B
Cancer Treat Rep; 1977 Dec; 61(9):1623-9. PubMed ID: 74281
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in squamous cell carcinoma of the lung.
Krzakowski MJ; Swierz J
Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study.
Richman SP; Livingston RB; Gutterman JU; Suen JY; Hersh EM
Cancer Treat Rep; 1976 May; 60(5):535-9. PubMed ID: 62613
[TBL] [Abstract][Full Text] [Related]
5. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
Edmonson JH; Lagakos S; Stolbach L; Perlia CP; Bennett JM; Mansour EG; Horton J; Regelson W; Cummings FJ; Israel L; Brodsky I; Shnider BI; Creech R; Carbone PP
Cancer Treat Rep; 1976 May; 60(5):625-7. PubMed ID: 186183
[No Abstract] [Full Text] [Related]
6. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
[TBL] [Abstract][Full Text] [Related]
7. Acute leukemia following combination chemotherapy for cancer of the lung.
May JT; Hsu SD; Costanzi JJ
Oncology; 1981; 38(3):134-7. PubMed ID: 6163119
[TBL] [Abstract][Full Text] [Related]
8. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
[TBL] [Abstract][Full Text] [Related]
9. CCNU-adriamycin therapy in bronchogenic carcinoma.
Trowbridge RC; Kennedy BJ; Vosika GJ
Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
[TBL] [Abstract][Full Text] [Related]
11. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
12. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
Alberto P; Barrelet L; Chapuis B; Garcia B
Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
[No Abstract] [Full Text] [Related]
13. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Santoro A; Viviani S; Valagussa P; Bonfante V; Bonadonna G
Semin Oncol; 1986 Mar; 13(1 Suppl 1):23-6. PubMed ID: 2420012
[TBL] [Abstract][Full Text] [Related]
14. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
15. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
16. Patterns of response and relapse in chemotherapy of extensive squamous carcinoma of the lung.
Livingston RB; Heilbrun LH
Cancer Chemother Pharmacol; 1978; 1(4):225-7. PubMed ID: 86393
[No Abstract] [Full Text] [Related]
17. Combined chemotherapy for squamous cell carcinoma of the lung.
Hyde L; Wolf J; Phillips R; Mietlowski W
Chest; 1978 May; 73(5):603-7. PubMed ID: 648211
[TBL] [Abstract][Full Text] [Related]
18. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
[TBL] [Abstract][Full Text] [Related]
19. Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB".
Bodey GP; Lagakos SW; Gutierrez AC; Wilson HE; Selawry OS
Cancer; 1977 Mar; 39(3):1026-31. PubMed ID: 71943
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
